Effects of Xiangdan Injection on pharmacokinetics and pharmacodynamics of warfarin in rats in vivo

JIANG Mei-ting1 ZHANG Wen-long1 SUN Zhi-dan1 ZHOU Yang-xu1 CHEN Jia-yu1 LIU Gao-feng1

(1.Key Laboratory of University in Heilongjiang Province, Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China 150086)

【Abstract】This study aimed at exploring the effect of Xiangdan Injection on anticoagulation of warfarin in rats in vivo. Rats were randomly assigned into different groups and then administered. Subsequently, the blood samples were collected at a set series of time points for the measurement of prothrombin time (PT) and activated partial thromboplastin time (APTT) values, and the international normalized ratio (INR) was calculated. The plasma concentrations of warfarin enantiomers were determined by UPLC-MS/MS technology, and pharmacokinetic parameters were calculated by DAS 2.0 software. Statistical analysis was performed to compare differences between the groups. Single-dose study of warfarin showed that Xiangdan Injection alone had no effects on PT, APTT or INR. When Xiangdan Injection was co-administered with warfarin, PT and INR values increased (P < 0.01), while APTT was unaffected; after co-administration of the two drugs, Cmax, AUC0-t, and AUC0-∞ of S-warfarin increased (P < 0.01), and t1/2 prolonged (P < 0.01), while the pharmacokinetic parameters of R-warfarin changed insignificantly. Steady-state study of warfarin showed that after co-administration of the two drugs, the PT and INR values increased (P < 0.05), and the plasma concentration of S-warfarin increased (P < 0.01), while the plasma concentration of R-warfarin changed insignificantly. The results have suggested that Xiangdan Injection itself has no effect on coagulation index while can enhance the anticoagulation of warfarin by delaying the metabolism of S-warfarin.

【Keywords】 Xiangdan Injection; warfarin; anticoagulation; drug interactions; pharmacodynamics; pharmacokinetics;


【Funds】 National Natural Science Foundation of China (81173659)

Download this article


    [1] MENG L, DING C Y, AN J, et al. Research progress in clinical treatment of oral anticoagulants [J]. Pharmaceutical Care and Research, 2019, 19 (3): 166 (in Chinese).

    [2] HIRSH J, FUSTER V, ANSELL J, et al. American heart association/American college of cardiology foundation guide to warfarin therapy [J]. J Am Coll Cardiol, 2003, 41 (9): 1633.

    [3] AAOM clinical practice statement: management of patients on warfarin therapy [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2016, 122 (6): 702.

    [4] LI H G, FAN R, MA N, et al. Research progress on pharmacokinetics factors of warfarin [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22 (11): 1292 (in Chinese).

    [5] Cardiovascular Disease Branch of Chinese Medical Association, Cardiovascular and Cerebrovascular Disease Professional Committee of Gerontological Society of China. 华法林抗凝治疗的中国专家共识 [J]. Chinese Journal of Internal Medicine, 2013, 52 (1): 76 (in Chinese).

    [6] GAO T, YANG L J, SHENG X K, et al. Analysis of chemical constituents of Xiangdan Injection by HPLC-Q-TOF/MS and GC/MS [J]. Chinese Traditional Patent Medicine, 2019, 41 (2): 107 (in Chinese).

    [7] ZENG S N. Curative effect of Xiangdan Injection in treating coronary heart disease stenocardia and drug safety analysis [J]. Journal of China Prescription Drug, 2017, 15 (1): 4 (in Chinese).

    [8] LUO Y, ZHANG Y, ZHANG X Y. Clinical observation of treating the acute phase of NSTEMI with Shenfu Injection plus Xiangdan Injection [J]. Journal of Emergency in Traditional Chinese Medicine, 2009, 18 (4): 554 (in Chinese).

    [9] HU X, WEI F. 中药注射剂治疗常见心血管疾病的研究进展 [J]. Chinese Journal of Clinical Rational Drug Use, 2015, 8 (26): 172 (in Chinese).

    [10] XUE Q D, JU A X, WANG P, et al. Effects of Compound Danshen Injection on activity of different subtypes of cytochrome P450 in rats [J]. Chinese Journal of Experimental Traditional Medical Formulae, 2015, 21 (14): 71 (in Chinese).

    [11] XU S Y, BIAN R L, CHEN X. 药理实验方法学 [M]. 3rd Ed. Beijing: People’s Medical Publishing House, 2002: 202 (in Chinese).

    [12] FENG L Y, LIANG X L, LI T T, et al. Influence of Danhong Injection on anticoagulant effect of warfarin in rats in vivo [J]. China Pharmacist, 2016, 19 (1): 1 (in Chinese).

    [13] ZHANG C Y. PT、APTT、TT、Fg检测及临床应用 [J]. China Practical Medical, 2015, 10 (7): 108 (in Chinese).

    [14] XIE H J, FU H Y, ZHU C F, et al. Effects of Danshen Injection (Salvia miltiorrhiza) on pharmacodynamics and pharamcokinetics of warfarin in rats [J]. Herald of Medicine, 2009, 28 (1): 36 (in Chinese).

    [15] SUN J, LU Y, LI Y, et al. Influence of Shenxiong Glucose Injection on the activities of six CYP isozymes and metabolism of warfarin in rats assessed using probe cocktail and pharmacokinetic approaches [J]. Molecules, 2017, 22 (11): 7.

    [16] ZHU J P, ZHAO R. Influence factors for the pharmacodynamics of warfarin [J]. Clinical Medication Journal, 2009, 7 (3): 55 (in Chinese).

    [17] HAN J Y. Research progress of pharmacist-participated warfarin anticoagulation manage [J]. Chinese Journal of Modern Applied Pharmacy, 2018, 35 (8): 1269 (in Chinese).

This Article


CN: 11-2272/R

Vol 45, No. 19, Pages 4740-4745

October 2020


Article Outline


  • 1 Materials
  • 2 Methods
  • 3 Results
  • 4 Discussion
  • References